Viewing Study NCT00906334


Ignite Creation Date: 2025-12-25 @ 2:26 AM
Ignite Modification Date: 2025-12-27 @ 10:58 PM
Study NCT ID: NCT00906334
Status: COMPLETED
Last Update Posted: 2017-06-26
First Post: 2009-05-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of ON 01910.Na in Myelodysplastic Syndrome (MDS) Patients With Trisomy 8 or Classified as Intermediate-1, -2 or High Risk
Sponsor: Traws Pharma, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module